In this issue we talk with …
… Lilly’s Dr Mike Hutton
The company’s chief scientific officer for neurodegenerative diseases talks about the future for Alzheimer’s research …
And we take a look at …
… Value-added services
Going ‘beyond the pill’ offers new opportunities and advantages for pharma …
… Medical devices regulation
European changes come at a critical time for the sector …
… The ASEAN vaccines market
Do domestic players in the South-East Asian bloc present a threat or an opportunity …
… Counting what counts
The value of investing in communications analytics …
Also with this issue …
… Digital Intelligence
Mobile health apps and their, as yet, unrealised potential
… R&D Pipeline
New therapies for major depressive disorder
… Innovation Update
European pharma job cuts are releasing talent that’s driving the development of bioclusters …
and in addition …
… Strategic communications for orphan drugs
PME’s next Orphan Drugs and Rare Diseases supplement tackles how to meet communications challenges …
… Inside: CROs
PME’s annual contract research guide; includes features on adaptive trials, digital technology and extensive CRO capability charts …
Register here to receive email notification of future digital editions of PME or contact the subscriptions department to enquire about receiving a print copy of the magazine. More PMLiVE digital editions can be found here.
PME is also available to download as an app for iPhone, iPad, Android and Kindle Fire
